NASDAQ Companies

First abstract highlights pre-clinical data linking lenabasum’s mechanism of action to inhibiting inflammasome activationSecond abstract outlines baseline characteristics of RESOLVE-1 […]

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading […]

AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage […]

Director Elections to the Board of Directors AnnouncedNew Officer Elections AnnouncedDirector Elections to the Board of DirectorsCEDAR RAPIDS, Iowa, May […]

SOUTH SAN FRANCISCO, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]

DEVON, Pa., May 22, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]

BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today […]

MENLO PARK, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced […]

OTTAWA, May 22, 2020 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection […]